SIMILAR PATTERNS OF AMINO ACIDS FOR 4RJD_A_TFPA203
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1avs | TROPONIN C (Gallus gallus) |
PF13833(EF-hand_8) | 4 | PHE A 29ILE A 37LEU A 42MET A 81 | None | 0.50A | 4rjdA-1avsA:12.4 | 4rjdA-1avsA:46.67 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1ggz | CALMODULIN-RELATEDPROTEIN NB-1 (Homo sapiens) |
PF13499(EF-hand_7) | 5 | PHE A 19ILE A 27LEU A 32MET A 51VAL A 63 | NoneNoneNoneNone CA A 150 ( 4.9A) | 0.55A | 4rjdA-1ggzA:14.0 | 4rjdA-1ggzA:83.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1ggz | CALMODULIN-RELATEDPROTEIN NB-1 (Homo sapiens) |
PF13499(EF-hand_7) | 5 | PHE A 92LEU A 105MET A 109MET A 124VAL A 136 | None | 0.42A | 4rjdA-1ggzA:14.0 | 4rjdA-1ggzA:83.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1ggz | CALMODULIN-RELATEDPROTEIN NB-1 (Homo sapiens) |
PF13499(EF-hand_7) | 5 | PHE A 92LEU A 105MET A 124ALA A 128VAL A 136 | None | 0.33A | 4rjdA-1ggzA:14.0 | 4rjdA-1ggzA:83.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1lln | ANTIVIRAL PROTEIN 3 (Phytolaccaamericana) |
PF00161(RIP) | 4 | ILE A 63LEU A 68ALA A 24VAL A 48 | None | 0.63A | 4rjdA-1llnA:undetectable | 4rjdA-1llnA:18.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1oqp | CALTRACTIN (Chlamydomonasreinhardtii) |
PF13499(EF-hand_7) | 5 | PHE A 110ILE A 118LEU A 123MET A 142ALA A 146 | None | 0.64A | 4rjdA-1oqpA:12.4 | 4rjdA-1oqpA:45.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1qx2 | VITAMIN D-DEPENDENTCALCIUM-BINDINGPROTEIN, INTESTINAL (Bos taurus) |
PF00036(EF-hand_1) | 4 | PHE A 13ILE A 23VAL A 61MET A 69 | None | 0.54A | 4rjdA-1qx2A:7.7 | 4rjdA-1qx2A:45.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1wrk | TROPONIN C, SLOWSKELETAL AND CARDIACMUSCLES (Homo sapiens) |
PF13833(EF-hand_8) | 4 | ILE A 36LEU A 41MET A 60VAL A 72 | NoneNoneTFP A 202 ( 4.0A)None | 0.45A | 4rjdA-1wrkA:10.6 | 4rjdA-1wrkA:44.29 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1zot | CALMODULIN (Homo sapiens) |
PF13499(EF-hand_7) | 4 | ILE B 100LEU B 105MET B 109MET B 144 | None | 0.67A | 4rjdA-1zotB:13.0 | 4rjdA-1zotB:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1zot | CALMODULIN (Homo sapiens) |
PF13499(EF-hand_7) | 4 | ILE B 100LEU B 105MET B 109VAL B 136 | NoneNoneNone CA B 800 ( 4.9A) | 0.34A | 4rjdA-1zotB:13.0 | 4rjdA-1zotB:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1zot | CALMODULIN (Homo sapiens) |
PF13499(EF-hand_7) | 5 | ILE B 100LEU B 105MET B 124ALA B 128VAL B 136 | NoneNoneNoneNone CA B 800 ( 4.9A) | 0.36A | 4rjdA-1zotB:13.0 | 4rjdA-1zotB:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1zot | CALMODULIN (Homo sapiens) |
PF13499(EF-hand_7) | 5 | PHE B 92ILE B 100LEU B 105MET B 124VAL B 136 | NoneNoneNoneNone CA B 800 ( 4.9A) | 0.52A | 4rjdA-1zotB:13.0 | 4rjdA-1zotB:100.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ccm | CALEXCITIN (Doryteuthispealeii) |
no annotation | 4 | ILE A 30ALA A 73VAL A 81MET A 89 | None | 0.57A | 4rjdA-2ccmA:4.8 | 4rjdA-2ccmA:18.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2f2p | CALMODULIN FUSEDWITHCALMODULIN-BINDINGDOMAIN OFCALCINEURIN (Bos taurus) |
PF13499(EF-hand_7) | 4 | ILE A 100LEU A 105MET A 109MET A 124 | None | 0.71A | 4rjdA-2f2pA:13.2 | 4rjdA-2f2pA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2f2p | CALMODULIN FUSEDWITHCALMODULIN-BINDINGDOMAIN OFCALCINEURIN (Bos taurus) |
PF13499(EF-hand_7) | 4 | PHE A 19ILE A 27LEU A 32MET A 36 | None | 0.50A | 4rjdA-2f2pA:13.2 | 4rjdA-2f2pA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2f2p | CALMODULIN FUSEDWITHCALMODULIN-BINDINGDOMAIN OFCALCINEURIN (Bos taurus) |
PF13499(EF-hand_7) | 4 | PHE A 19ILE A 27LEU A 32MET A 51 | None | 0.35A | 4rjdA-2f2pA:13.2 | 4rjdA-2f2pA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2f2p | CALMODULIN FUSEDWITHCALMODULIN-BINDINGDOMAIN OFCALCINEURIN (Bos taurus) |
PF13499(EF-hand_7) | 6 | PHE A 92ILE A 100LEU A 105ALA A 128VAL A 136MET A 144 | NoneNoneNoneNone CA A1004 ( 4.9A)None | 0.45A | 4rjdA-2f2pA:13.2 | 4rjdA-2f2pA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2f2p | CALMODULIN FUSEDWITHCALMODULIN-BINDINGDOMAIN OFCALCINEURIN (Bos taurus) |
PF13499(EF-hand_7) | 6 | PHE A 92ILE A 100LEU A 105MET A 109ALA A 128VAL A 136 | NoneNoneNoneNoneNone CA A1004 ( 4.9A) | 0.43A | 4rjdA-2f2pA:13.2 | 4rjdA-2f2pA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2ggm | CENTRIN-2 (Homo sapiens) |
PF13499(EF-hand_7) | 5 | ILE A 121LEU A 126MET A 145ALA A 149VAL A 157 | None | 0.49A | 4rjdA-2ggmA:13.1 | 4rjdA-2ggmA:30.56 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2ggm | CENTRIN-2 (Homo sapiens) |
PF13499(EF-hand_7) | 4 | PHE A 113ILE A 121LEU A 126MET A 145 | None | 0.65A | 4rjdA-2ggmA:13.1 | 4rjdA-2ggmA:30.56 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2jjz | IONIZEDCALCIUM-BINDINGADAPTER MOLECULE 2 (Homo sapiens) |
no annotation | 4 | ILE B 67LEU B 72MET B 76MET B 111 | None | 0.70A | 4rjdA-2jjzB:8.0 | 4rjdA-2jjzB:18.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2jjz | IONIZEDCALCIUM-BINDINGADAPTER MOLECULE 2 (Homo sapiens) |
no annotation | 4 | ILE B 67LEU B 72MET B 91MET B 111 | None | 0.64A | 4rjdA-2jjzB:8.0 | 4rjdA-2jjzB:18.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2k2i | CENTRIN-2 (Homo sapiens) |
PF13499(EF-hand_7) | 5 | ILE A 121LEU A 126MET A 145ALA A 149VAL A 157 | None | 0.68A | 4rjdA-2k2iA:10.6 | 4rjdA-2k2iA:51.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2k7d | CALCIUM-BINDINGPROTEIN 1 (Homo sapiens) |
PF13499(EF-hand_7) | 4 | ILE A 119LEU A 124VAL A 156MET A 164 | None | 0.63A | 4rjdA-2k7dA:9.5 | 4rjdA-2k7dA:43.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2kn2 | CALMODULIN (Glycine max) |
PF13499(EF-hand_7) | 5 | ILE A 26LEU A 31MET A 35ALA A 54VAL A 62 | NoneNoneNoneNone CA A 209 ( 4.5A) | 0.58A | 4rjdA-2kn2A:11.3 | 4rjdA-2kn2A:80.60 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2kn2 | CALMODULIN (Glycine max) |
PF13499(EF-hand_7) | 5 | ILE A 26LEU A 31MET A 35MET A 50VAL A 62 | NoneNoneNoneNone CA A 209 ( 4.5A) | 1.08A | 4rjdA-2kn2A:11.3 | 4rjdA-2kn2A:80.60 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2kn2 | CALMODULIN (Glycine max) |
PF13499(EF-hand_7) | 5 | PHE A 18ILE A 26LEU A 31ALA A 54VAL A 62 | NoneNoneNoneNone CA A 209 ( 4.5A) | 0.37A | 4rjdA-2kn2A:11.3 | 4rjdA-2kn2A:80.60 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2kn2 | CALMODULIN (Glycine max) |
PF13499(EF-hand_7) | 5 | PHE A 18ILE A 26LEU A 31MET A 50VAL A 62 | NoneNoneNoneNone CA A 209 ( 4.5A) | 0.88A | 4rjdA-2kn2A:11.3 | 4rjdA-2kn2A:80.60 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2l1w | CALMODULIN (Glycine max) |
PF13499(EF-hand_7) | 5 | ILE A 100LEU A 105ALA A 128VAL A 136MET A 144 | NoneNoneNone CA A 234 ( 4.6A)None | 0.72A | 4rjdA-2l1wA:10.5 | 4rjdA-2l1wA:80.60 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2l1w | CALMODULIN (Glycine max) |
PF13499(EF-hand_7) | 5 | ILE A 100LEU A 105MET A 109VAL A 136MET A 144 | NoneNoneNone CA A 234 ( 4.6A)None | 0.71A | 4rjdA-2l1wA:10.5 | 4rjdA-2l1wA:80.60 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2l1w | CALMODULIN (Glycine max) |
PF13499(EF-hand_7) | 5 | PHE A 92ILE A 100LEU A 105MET A 124VAL A 136 | NoneNoneNoneNone CA A 234 ( 4.6A) | 0.66A | 4rjdA-2l1wA:10.5 | 4rjdA-2l1wA:80.60 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2l1w | CALMODULIN (Glycine max) |
PF13499(EF-hand_7) | 5 | PHE A 92ILE A 100LEU A 105VAL A 136MET A 144 | NoneNoneNone CA A 234 ( 4.6A)None | 0.44A | 4rjdA-2l1wA:10.5 | 4rjdA-2l1wA:80.60 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2lmv | CALMODULIN-RELATEDPROTEIN 97A (Drosophilamelanogaster) |
PF13499(EF-hand_7) | 5 | PHE A 92ILE A 100LEU A 105MET A 109MET A 124 | None | 0.96A | 4rjdA-2lmvA:3.0 | 4rjdA-2lmvA:72.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2n6a | HUMANCALMODULIN/CONNEXIN-36 PEPTIDE HYBRID (Homo sapiens) |
PF13499(EF-hand_7) | 5 | ILE A 100LEU A 105MET A 109ALA A 128VAL A 136 | None | 0.82A | 4rjdA-2n6aA:10.9 | 4rjdA-2n6aA:98.51 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2n6a | HUMANCALMODULIN/CONNEXIN-36 PEPTIDE HYBRID (Homo sapiens) |
PF13499(EF-hand_7) | 6 | PHE A 92ILE A 100LEU A 105ALA A 128VAL A 136MET A 144 | None | 0.91A | 4rjdA-2n6aA:10.9 | 4rjdA-2n6aA:98.51 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2n6a | HUMANCALMODULIN/CONNEXIN-36 PEPTIDE HYBRID (Homo sapiens) |
PF13499(EF-hand_7) | 5 | PHE A 92ILE A 100LEU A 105MET A 124MET A 144 | None | 1.01A | 4rjdA-2n6aA:10.9 | 4rjdA-2n6aA:98.51 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2obh | CENTRIN-2 (Homo sapiens) |
PF13499(EF-hand_7) | 5 | ILE A 121LEU A 126MET A 145ALA A 149VAL A 157 | NoneNoneNoneNone CA A1001 ( 4.9A) | 0.47A | 4rjdA-2obhA:13.3 | 4rjdA-2obhA:30.28 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2obh | CENTRIN-2 (Homo sapiens) |
PF13499(EF-hand_7) | 5 | PHE A 113ILE A 121LEU A 126MET A 145VAL A 157 | NoneNoneNoneNone CA A1001 ( 4.9A) | 0.64A | 4rjdA-2obhA:13.3 | 4rjdA-2obhA:30.28 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2ro9 | CALMODULIN-2 (Glycine max) |
PF13499(EF-hand_7) | 4 | ILE A 100LEU A 105MET A 109ALA A 128 | None | 0.43A | 4rjdA-2ro9A:13.0 | 4rjdA-2ro9A:86.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2ro9 | CALMODULIN-2 (Glycine max) |
PF13499(EF-hand_7) | 4 | PHE A 92ILE A 100LEU A 105ALA A 128 | None | 0.42A | 4rjdA-2ro9A:13.0 | 4rjdA-2ro9A:86.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2rob | CALMODULIN (Glycine max) |
PF13499(EF-hand_7) | 4 | ILE A 100ALA A 128VAL A 136MET A 144 | None | 0.58A | 4rjdA-2robA:11.5 | 4rjdA-2robA:80.60 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2rob | CALMODULIN (Glycine max) |
PF13499(EF-hand_7) | 4 | ILE A 100LEU A 105ALA A 128VAL A 136 | None | 0.67A | 4rjdA-2robA:11.5 | 4rjdA-2robA:80.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2sas | SARCOPLASMICCALCIUM-BINDINGPROTEIN (Branchiostomalanceolatum) |
PF13833(EF-hand_8) | 5 | ILE A 26LEU A 18ALA A 69VAL A 77MET A 85 | None | 1.38A | 4rjdA-2sasA:5.2 | 4rjdA-2sasA:20.71 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3b32 | CALMODULIN (Rattusnorvegicus) |
PF13499(EF-hand_7) | 4 | PHE A 19ILE A 27LEU A 32MET A 51 | None | 0.43A | 4rjdA-3b32A:12.9 | 4rjdA-3b32A:46.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3bdl | STAPHYLOCOCCALNUCLEASEDOMAIN-CONTAININGPROTEIN 1 (Homo sapiens) |
PF00565(SNase)PF00567(TUDOR) | 4 | PHE A 582LEU A 496ALA A 504VAL A 571 | None | 0.66A | 4rjdA-3bdlA:undetectable | 4rjdA-3bdlA:8.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3eag | UDP-N-ACETYLMURAMATE:L-ALANYL-GAMMA-D-GLUTAMYL-MESO-DIAMINOPIMELATE LIGASE (Neisseriameningitidis) |
PF01225(Mur_ligase)PF08245(Mur_ligase_M) | 4 | ILE A 48LEU A 46ALA A 21VAL A 28 | None | 0.70A | 4rjdA-3eagA:undetectable | 4rjdA-3eagA:13.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3evr | MYOSIN LIGHT CHAINKINASE, GREENFLUORESCENT PROTEIN,CALMODULIN-1 CHIMERA (Aequoreavictoria;Rattusnorvegicus) |
PF01353(GFP)PF13499(EF-hand_7) | 5 | ILE A 403LEU A 408MET A 412ALA A 431VAL A 439 | None | 0.47A | 4rjdA-3evrA:13.1 | 4rjdA-3evrA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3evr | MYOSIN LIGHT CHAINKINASE, GREENFLUORESCENT PROTEIN,CALMODULIN-1 CHIMERA (Aequoreavictoria;Rattusnorvegicus) |
PF01353(GFP)PF13499(EF-hand_7) | 4 | PHE A 322ILE A 330LEU A 335MET A 354 | None | 0.42A | 4rjdA-3evrA:13.1 | 4rjdA-3evrA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3evr | MYOSIN LIGHT CHAINKINASE, GREENFLUORESCENT PROTEIN,CALMODULIN-1 CHIMERA (Aequoreavictoria;Rattusnorvegicus) |
PF01353(GFP)PF13499(EF-hand_7) | 4 | PHE A 322ILE A 330LEU A 335MET A 374 | None | 0.52A | 4rjdA-3evrA:13.1 | 4rjdA-3evrA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3evr | MYOSIN LIGHT CHAINKINASE, GREENFLUORESCENT PROTEIN,CALMODULIN-1 CHIMERA (Aequoreavictoria;Rattusnorvegicus) |
PF01353(GFP)PF13499(EF-hand_7) | 6 | PHE A 395ILE A 403LEU A 408MET A 427ALA A 431VAL A 439 | None | 0.48A | 4rjdA-3evrA:13.1 | 4rjdA-3evrA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3evr | MYOSIN LIGHT CHAINKINASE, GREENFLUORESCENT PROTEIN,CALMODULIN-1 CHIMERA (Aequoreavictoria;Rattusnorvegicus) |
PF01353(GFP)PF13499(EF-hand_7) | 5 | PHE A 395MET A 427ALA A 431VAL A 439MET A 447 | None | 0.96A | 4rjdA-3evrA:13.1 | 4rjdA-3evrA:100.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3fwb | CELL DIVISIONCONTROL PROTEIN 31 (Saccharomycescerevisiae) |
PF13499(EF-hand_7) | 4 | PHE A 105ILE A 113LEU A 118MET A 137 | None | 0.42A | 4rjdA-3fwbA:13.0 | 4rjdA-3fwbA:26.76 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ifk | CALMODULIN (Rattusnorvegicus) |
PF13499(EF-hand_7) | 6 | PHE A 19ILE A 27LEU A 32MET A 36MET A 51MET A 71 | None | 0.56A | 4rjdA-3ifkA:11.8 | 4rjdA-3ifkA:40.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3k21 | CALCIUM-DEPENDENTPROTEIN KINASE 3 (Plasmodiumfalciparum) |
PF13499(EF-hand_7) | 5 | PHE A 131ILE A 139LEU A 144MET A 168MET A 188 | None | 0.71A | 4rjdA-3k21A:11.3 | 4rjdA-3k21A:22.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3kf9 | CALTRACTIN (Scherffeliadubia) |
PF13499(EF-hand_7)PF13833(EF-hand_8) | 5 | ILE A 44LEU A 49MET A 53MET A 68MET A 88 | None | 0.77A | 4rjdA-3kf9A:12.8 | 4rjdA-3kf9A:31.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3kf9 | CALTRACTIN (Scherffeliadubia) |
PF13499(EF-hand_7)PF13833(EF-hand_8) | 5 | PHE A 36ILE A 44LEU A 49MET A 53MET A 68 | None | 0.56A | 4rjdA-3kf9A:12.8 | 4rjdA-3kf9A:31.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3kf9 | CALTRACTIN (Scherffeliadubia) |
PF13499(EF-hand_7)PF13833(EF-hand_8) | 6 | PHE A 109ILE A 117LEU A 122MET A 141ALA A 145VAL A 153 | None | 0.55A | 4rjdA-3kf9A:12.8 | 4rjdA-3kf9A:31.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3khe | CALMODULIN-LIKEDOMAIN PROTEINKINASE ISOFORM 3 (Toxoplasmagondii) |
PF13499(EF-hand_7) | 4 | PHE A 132ILE A 140VAL A 174MET A 182 | None | 0.50A | 4rjdA-3kheA:9.2 | 4rjdA-3kheA:18.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3l19 | CALCIUM/CALMODULINDEPENDENT PROTEINKINASE WITH A KINASEDOMAIN AND 4CALMODULIN LIKE EFHANDS (Cryptosporidiumparvum) |
PF13499(EF-hand_7) | 4 | ILE A 466LEU A 471VAL A 500MET A 508 | None | 0.51A | 4rjdA-3l19A:8.1 | 4rjdA-3l19A:15.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3l19 | CALCIUM/CALMODULINDEPENDENT PROTEINKINASE WITH A KINASEDOMAIN AND 4CALMODULIN LIKE EFHANDS (Cryptosporidiumparvum) |
PF13499(EF-hand_7) | 5 | PHE A 458ILE A 466LEU A 471MET A 488VAL A 500 | None | 0.80A | 4rjdA-3l19A:8.1 | 4rjdA-3l19A:15.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3lij | CALCIUM/CALMODULINDEPENDENT PROTEINKINASE WITH A KINASEDOMAIN AND 4CALMODULIN LIKE EFHANDS (Cryptosporidiumparvum) |
PF00069(Pkinase)PF13499(EF-hand_7) | 5 | ILE A 466LEU A 471MET A 488VAL A 500MET A 508 | None | 0.63A | 4rjdA-3lijA:8.9 | 4rjdA-3lijA:10.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3lij | CALCIUM/CALMODULINDEPENDENT PROTEINKINASE WITH A KINASEDOMAIN AND 4CALMODULIN LIKE EFHANDS (Cryptosporidiumparvum) |
PF00069(Pkinase)PF13499(EF-hand_7) | 4 | PHE A 458ILE A 466VAL A 500MET A 508 | None | 0.45A | 4rjdA-3lijA:8.9 | 4rjdA-3lijA:10.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3o4y | CALCIUM-DEPENDENTPROTEIN KINASE 3 (Plasmodiumvivax) |
PF13499(EF-hand_7)PF13833(EF-hand_8) | 4 | PHE A 134ILE A 142LEU A 147MET A 191 | None | 0.45A | 4rjdA-3o4yA:8.8 | 4rjdA-3o4yA:18.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ox5 | CALCIUM-BINDINGPROTEIN 1 (Homo sapiens) |
PF13499(EF-hand_7) | 4 | PHE A 111ILE A 119LEU A 124MET A 128 | None | 0.53A | 4rjdA-3ox5A:11.5 | 4rjdA-3ox5A:26.80 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3q5i | PROTEIN KINASE (Plasmodiumberghei) |
PF00069(Pkinase)PF13499(EF-hand_7) | 4 | PHE A 463ILE A 471LEU A 476MET A 513 | None | 0.68A | 4rjdA-3q5iA:8.4 | 4rjdA-3q5iA:9.28 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3qrx | CENTRIN (Chlamydomonasreinhardtii) |
PF13499(EF-hand_7) | 4 | PHE A 37ILE A 45LEU A 50MET A 54 | None | 0.54A | 4rjdA-3qrxA:12.9 | 4rjdA-3qrxA:52.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3qrx | CENTRIN (Chlamydomonasreinhardtii) |
PF13499(EF-hand_7) | 5 | PHE A 37ILE A 45LEU A 50MET A 69MET A 89 | None | 0.88A | 4rjdA-3qrxA:12.9 | 4rjdA-3qrxA:52.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3qrx | CENTRIN (Chlamydomonasreinhardtii) |
PF13499(EF-hand_7) | 5 | PHE A 110ILE A 118LEU A 123MET A 142ALA A 146 | None | 0.75A | 4rjdA-3qrxA:12.9 | 4rjdA-3qrxA:52.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3u0k | RCAMP (Entacmaeaquadricolor) |
PF01353(GFP)PF13499(EF-hand_7) | 4 | ILE A 321LEU A 326MET A 345MET A 365 | None | 0.51A | 4rjdA-3u0kA:13.7 | 4rjdA-3u0kA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3u0k | RCAMP (Entacmaeaquadricolor) |
PF01353(GFP)PF13499(EF-hand_7) | 4 | PHE A 313ILE A 321LEU A 326MET A 345 | None | 0.47A | 4rjdA-3u0kA:13.7 | 4rjdA-3u0kA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3u0k | RCAMP (Entacmaeaquadricolor) |
PF01353(GFP)PF13499(EF-hand_7) | 5 | PHE A 386ILE A 394LEU A 399MET A 403VAL A 430 | None | 0.49A | 4rjdA-3u0kA:13.7 | 4rjdA-3u0kA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3u0k | RCAMP (Entacmaeaquadricolor) |
PF01353(GFP)PF13499(EF-hand_7) | 6 | PHE A 386ILE A 394LEU A 399MET A 418ALA A 422VAL A 430 | None | 0.43A | 4rjdA-3u0kA:13.7 | 4rjdA-3u0kA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4gow | CALMODULIN (Homo sapiens) |
PF13499(EF-hand_7) | 7 | ILE D 100LEU D 105MET D 109MET D 124ALA D 128VAL D 136MET D 144 | ILE D 100 ( 0.7A)LEU D 105 ( 0.6A)MET D 109 ( 0.0A)MET D 124 ( 0.0A)ALA D 128 ( 0.0A)VAL D 136 ( 0.6A)MET D 144 ( 0.0A) | 0.80A | 4rjdA-4gowD:12.6 | 4rjdA-4gowD:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4gow | CALMODULIN (Homo sapiens) |
PF13499(EF-hand_7) | 4 | PHE D 19ILE D 27LEU D 32MET D 51 | PHE D 19 ( 1.3A)ILE D 27 ( 0.7A)LEU D 32 ( 0.6A)MET D 51 ( 0.0A) | 0.56A | 4rjdA-4gowD:12.6 | 4rjdA-4gowD:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4gow | CALMODULIN (Homo sapiens) |
PF13499(EF-hand_7) | 7 | PHE D 92ILE D 100LEU D 105MET D 109MET D 124ALA D 128VAL D 136 | PHE D 92 ( 1.3A)ILE D 100 ( 0.7A)LEU D 105 ( 0.6A)MET D 109 ( 0.0A)MET D 124 ( 0.0A)ALA D 128 ( 0.0A)VAL D 136 ( 0.6A) | 0.65A | 4rjdA-4gowD:12.6 | 4rjdA-4gowD:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4i2y | RGECO1 (Discosoma sp.;Gallus gallus;Rattusnorvegicus) |
PF01353(GFP)PF13499(EF-hand_7) | 5 | PHE A 322ILE A 330LEU A 335MET A 354MET A 374 | None | 0.72A | 4rjdA-4i2yA:11.9 | 4rjdA-4i2yA:95.45 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4i2y | RGECO1 (Discosoma sp.;Gallus gallus;Rattusnorvegicus) |
PF01353(GFP)PF13499(EF-hand_7) | 5 | PHE A 395ILE A 403LEU A 408MET A 412VAL A 439 | None | 0.41A | 4rjdA-4i2yA:11.9 | 4rjdA-4i2yA:95.45 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4i2y | RGECO1 (Discosoma sp.;Gallus gallus;Rattusnorvegicus) |
PF01353(GFP)PF13499(EF-hand_7) | 6 | PHE A 395ILE A 403LEU A 408MET A 427ALA A 431VAL A 439 | None | 0.48A | 4rjdA-4i2yA:11.9 | 4rjdA-4i2yA:95.45 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4i2y | RGECO1 (Discosoma sp.;Gallus gallus;Rattusnorvegicus) |
PF01353(GFP)PF13499(EF-hand_7) | 5 | PHE A 395MET A 427ALA A 431VAL A 439MET A 447 | None | 0.95A | 4rjdA-4i2yA:11.9 | 4rjdA-4i2yA:95.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4jwq | CALCIUM-DEPENDENTPROTEIN KINASE (Plasmodiumberghei) |
PF13499(EF-hand_7) | 4 | ILE A 145LEU A 150MET A 174MET A 194 | None | 0.63A | 4rjdA-4jwqA:11.6 | 4rjdA-4jwqA:17.20 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4oy4 | CHIMERA PROTEIN OFCALMODULIN, GPF-LIKEPROTEIN EOSFP, ANDMYOSIN LIGHT CHAINKINASE (Gallus gallus;Lobophylliahemprichii;Rattusnorvegicus) |
PF01353(GFP)PF13499(EF-hand_7) | 5 | PHE A 67ILE A 62LEU A 31MET A 35MET A 50 | None | 0.92A | 4rjdA-4oy4A:5.3 | 4rjdA-4oy4A:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4q57 | CALMODULIN (Homo sapiens) |
PF13499(EF-hand_7) | 4 | PHE A 19ILE A 27LEU A 32MET A 51 | None | 0.38A | 4rjdA-4q57A:13.8 | 4rjdA-4q57A:46.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4q57 | CALMODULIN (Homo sapiens) |
PF13499(EF-hand_7) | 4 | PHE A 19ILE A 27LEU A 32MET A 71 | None | 0.47A | 4rjdA-4q57A:13.8 | 4rjdA-4q57A:46.97 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4wpx | CELL DIVISIONCONTROL PROTEIN31-LIKE PROTEIN (Chaetomiumthermophilum) |
PF00036(EF-hand_1)PF13499(EF-hand_7) | 5 | PHE A 120ILE A 128LEU A 133MET A 152VAL A 164 | None | 0.63A | 4rjdA-4wpxA:12.1 | 4rjdA-4wpxA:22.14 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ysj | CALMODULIN-LIKEDOMAIN PROTEINKINASE (Eimeria tenella) |
PF00069(Pkinase)PF13499(EF-hand_7) | 4 | PHE A 427ILE A 435LEU A 440MET A 477 | None | 0.67A | 4rjdA-4ysjA:10.4 | 4rjdA-4ysjA:11.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ysj | CALMODULIN-LIKEDOMAIN PROTEINKINASE (Eimeria tenella) |
PF00069(Pkinase)PF13499(EF-hand_7) | 4 | PHE A 427ILE A 435VAL A 469MET A 477 | None | 0.30A | 4rjdA-4ysjA:10.4 | 4rjdA-4ysjA:11.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5coc | IMMUNOGLOBULING-BINDING PROTEINA,CALMODULIN (Homo sapiens;Staphylococcusaureus) |
PF02216(B)PF13499(EF-hand_7) | 4 | PHE A1020ILE A1028LEU A1033MET A1052 | None | 0.57A | 4rjdA-5cocA:12.7 | 4rjdA-5cocA:27.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5coc | IMMUNOGLOBULING-BINDING PROTEINA,CALMODULIN (Homo sapiens;Staphylococcusaureus) |
PF02216(B)PF13499(EF-hand_7) | 4 | PHE A1020ILE A1028LEU A1033MET A1072 | None | 0.70A | 4rjdA-5cocA:12.7 | 4rjdA-5cocA:27.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5d43 | CENTRIN-1 (Mus musculus) |
PF13499(EF-hand_7)PF13833(EF-hand_8) | 6 | PHE A 113ILE A 121LEU A 126MET A 145ALA A 149VAL A 157 | NoneNoneNoneNoneNone CA A1204 ( 4.9A) | 0.36A | 4rjdA-5d43A:12.9 | 4rjdA-5d43A:30.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5djs | TETRATRICOPEPTIDETPR_2 REPEAT PROTEIN (Thermobaculumterrenum) |
PF13181(TPR_8)PF13844(Glyco_transf_41) | 4 | ILE A 240LEU A 163ALA A 519VAL A 263 | None | 0.70A | 4rjdA-5djsA:undetectable | 4rjdA-5djsA:7.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5i2q | EF-HANDDOMAIN-CONTAININGPROTEIN D2 (Homo sapiens) |
PF13405(EF-hand_6) | 4 | ILE A 112LEU A 117MET A 121MET A 136 | None | 0.68A | 4rjdA-5i2qA:9.7 | 4rjdA-5i2qA:20.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5kzs | PUTATIVE CELLSURFACE PROTEIN,SIMILAR TOINTERNALIN PROTEINS (Listeriamonocytogenes) |
PF12354(Internalin_N)PF13855(LRR_8) | 4 | PHE A 80ILE A 85LEU A 50MET A 54 | None | 0.66A | 4rjdA-5kzsA:undetectable | 4rjdA-5kzsA:10.22 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ukg | K-GECO (Entacmaeaquadricolor) |
no annotation | 5 | ILE A 365LEU A 370MET A 389ALA A 393VAL A 401 | None | 0.69A | 4rjdA-5ukgA:11.7 | 4rjdA-5ukgA:17.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ukg | K-GECO (Entacmaeaquadricolor) |
no annotation | 4 | PHE A 284ILE A 292LEU A 297MET A 301 | None | 0.63A | 4rjdA-5ukgA:11.7 | 4rjdA-5ukgA:17.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ukg | K-GECO (Entacmaeaquadricolor) |
no annotation | 4 | PHE A 284ILE A 292LEU A 297MET A 316 | None | 0.51A | 4rjdA-5ukgA:11.7 | 4rjdA-5ukgA:17.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ukg | K-GECO (Entacmaeaquadricolor) |
no annotation | 5 | PHE A 357ILE A 365LEU A 370ALA A 393VAL A 401 | None | 0.66A | 4rjdA-5ukgA:11.7 | 4rjdA-5ukgA:17.72 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5w88 | TROPONIN C, TROPONINI (Homo sapiens) |
PF00992(Troponin)PF13833(EF-hand_8) | 4 | ILE A 36LEU A 41MET A 45VAL A 72 | 9XG A 201 ( 3.3A)9XG A 201 (-3.9A)9XG A 201 (-2.4A)9XG A 201 (-3.8A) | 0.64A | 4rjdA-5w88A:8.1 | 4rjdA-5w88A:33.67 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5w88 | TROPONIN C, TROPONINI (Homo sapiens) |
PF00992(Troponin)PF13833(EF-hand_8) | 4 | ILE A 36LEU A 41MET A 60VAL A 72 | 9XG A 201 ( 3.3A)9XG A 201 (-3.9A)9XG A 201 (-4.0A)9XG A 201 (-3.8A) | 0.34A | 4rjdA-5w88A:8.1 | 4rjdA-5w88A:33.67 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5w88 | TROPONIN C, TROPONINI (Homo sapiens) |
PF00992(Troponin)PF13833(EF-hand_8) | 4 | PHE A 27LEU A 41MET A 60VAL A 72 | 9XG A 201 (-3.8A)9XG A 201 (-3.9A)9XG A 201 (-4.0A)9XG A 201 (-3.8A) | 0.58A | 4rjdA-5w88A:8.1 | 4rjdA-5w88A:33.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5z5k | NETRIN RECEPTOR DCC (Rattusnorvegicus) |
no annotation | 4 | ILE A 199MET A 153ALA A 151VAL A 157 | None | 0.69A | 4rjdA-5z5kA:undetectable | 4rjdA-5z5kA:18.18 |